Quick Links
Resources
About myHIVteam
Powered By
For Those On The Bimonthly Shots Of Cabenuva, Would You Consider The Twice-yearly Sunlenca?
The U.S. Food and Drug Administration (FDA) approved Sunlenca (lenacapavir) on December 22, 2022. Sunlenca is a long-acting antiretroviral medication used to treat HIV-1 in adults who have multi-drug resistant (MDR) HIV-1 infections or have been heavily treated (HTE) for HIV. It's used in combination with other antiretrovirals and is administered as a subcutaneous injection every six months after the initial dose. Sunlenca was approved based on research involving 72 people with HIV who had high… read more
Yes that’s my understanding Brad
I understand what Ron said right now the fda only recommends sunlenca to those who have viral resistance and they must take other ARVs on top of it. But gilead believes in the future this medicine can be a life changer for everyone and without other ARVs . Only time will tell
@A myHIVteam Member, according to their website, you take pills at the very beginning, then switch over to just the shots.
My understanding you still have to take pills with Sunlenca - not sure! Yet if that’s the case I wouldn’t want it - I want these pills gone
Hi Guys
Injections
Shots
Sign up for free!
Continue with Facebook
Sign up with your email
A myHIVte...
